The Pirbright Institute, supported by an $8.2 million grant from the Bezos Earth Fund, is exploring the feasibility of a methane vaccine for cattle to significantly reduce methane emissions and combat climate change.
Understanding How to Create Effective Antibodies to Reduce Methane in Cattle
The Pirbright Institute is exploring the feasibility of a methane vaccine for cattle, aiming to reduce methane emissions by over 30%. Methane from livestock significantly contributes to global warming, and this project targets methanogens – methane-producing microbes in the cattle’s rumen (the first stomach compartment). By partnering with AgResearch in New Zealand and the Royal Veterinary College (RVC), the project benefits from the unique strengths and resources of each institution.
The research focuses on identifying antibodies that can neutralize methanogens. Scientists are studying naturally occurring antibodies in cattle and developing new ones in lab and controlled environments. This approach aims to find the most effective way to reduce methane production in cattle.
This project seeks to establish a proof of concept for antibodies that can effectively reduce methane emissions from livestock. By addressing key knowledge gaps and using advanced scientific methods, this collaborative research could significantly contribute to global efforts to combat climate change.
This initiative exemplifies the high-risk, high-reward ventures supported by the Bezos Earth Fund, highlighting the potential for innovative solutions to environmental challenges.
Related News
-
Press Release